Citations

Clear

6273 citation(s) found for "To, Andrew".

Utility of formalin-fixed, paraffin-embedded prostate biospecimens from low-resource settings for use in next-generation sequencing studies in African-descent populations
Kaninjing, Ernest , Adeniji, Kayode , Gachii, Andrew , Jibrin, Paul, Obafunwa, John , Ogo, Chidiebere, Faruk, Mohammed , Popoola, Ademola , Fatiregun, Omolara , Oluwole, Olabode P., Aiken, William , Roberts, Robin , Jyoti, Shravana Kumar, Dial, Chérif , Niang, Lamine, Ndoye, Médina , Karanam, Balasubramanyam , Francis, Damian , Gibbs, Denise , Brignole, Kathryn R. , Yates, Clayton , Ragin, Camille, Martin, Damali N. , Kaninjing, Ernest T , Mohammed, Faruk , Popoola, Ademola A , Fatiregun, Omolara , Jackson, Maria D. , Jalloh, Mohamed , White, Jason , Ragin, Camille

Mayo Clinic

Journal of Global Health Reports | August 10, 2023 | Volume: 7 | Issue: No issue available | Pages: No page available

10.29392/001c.84541 Get It

Background Men of African ancestry experience higher burden from prostate cancer compared to men of other ancestral backgrounds. Limitations in the availability of high-quality biospecimens hinder the inclusion of this population in genetic studies of prostate cancer. The use of formalin-fixed paraffin-embedded (FFPE) tissues represent a potential rich source of genetic material particularly in some international settings, where fresh frozen tissue is difficult to obtain. In this study, we investigate the feasibility of using FFPE biospecimens acquired from various international sites for utility in next-generation sequencing. Methods A total of 976 FFPE blocks were collected between 2002 and 2017 from six international sites in Africa and the Caribbean representing three consortia: Prostate Cancer Transatlantic Consortium; African-Caribbean Cancer Consortium; and Men of African Descent and Carcinoma of the Prostate. Genomic DNA was checked for quality and quantity. Differences in mean quality control (QC) for pre-and-post pathology training were assessed using t-test. Pearson chi-square with trend analysis examined association between time-category and QC success status. Association of continuous DNA quality (Q129/Q41 ratio) and time of specimen collection was estimated with linear regression. Samples with a DNA quantity >0.2µg and a Q129/Q41 ratio >0.00225 were submitted for whole exome sequencing (WES). Results There was a positive relative percentage change in DNA quantity from 2002 to 2017 for Jamaica, Kenya and Senegal. There was a decline in DNA quantity over the same time period for Nigeria. There was a statistically significant improvement in quality of samples from Kenya ( P =0.032), Nigeria ( P <.001) and Senegal ( P =0.043). There was a significant improvement in the collected DNA sample quality over time with an R 2 of 0.12. Conclusions FFPE samples from low-resource settings could potentially provide sufficient DNA for WES. Improvements in biospecimen collection processing and storage for research are needed in some of these settings.
Antibiograms of select anaerobic bacteria over 10 years
Sterner, Rosalie M. , Shannon, Samantha, Estes, Lynn L., Norgan, Andrew P. , Schuetz, Audrey N.

Mayo Clinic

The Journal of Immunology | August 10, 2023 | Volume: 210 | Issue: Supplement_1 | Pages: 241.20-241.20

10.4049/jimmunol.210.supp.241.20 Get It

Abstract Antibiotics are critical complements to the immune response in combatting infection. Anaerobic bacteria are increasingly common causes of infection, and antibiotic resistance of anaerobes has been rising. Most laboratories do not perform antimicrobial susceptibility testing of anaerobes, and even fewer have compiled antibiogram data. Here we investigated antimicrobial susceptibility results of anaerobes from January 2012 to December 2021 obtained from inpatients at Mayo Clinic using reference agar dilution testing. Actinomyces (60–70 isolates annually), Bacteroides fragilis (30–80), Finegoldia magna (40–60), and Cutibacterium acnes (70–110) were included. Penicillin, clindamycin, metronidazole, ertapenem, piperacillin-tazobactam, and moxifloxacin were tested. Clinical and Laboratory Standards (CLSI) breakpoints were followed. B. fragilis showed ≥90% and Actinomyces 100% susceptibility to piperacillin-tazobactam and ertapenem. All F. magna and &gt;95% B. fragilis were susceptible to metronidazole. The most striking fluctuations in percent susceptibility from year to year were observed for clindamycin, with Actinomyces ranging from 66–79%, B. fragilis 34–67%, and F. magna 47–85%. In the absence of local anaerobe antibiograms, providers may refer to such antibiogram data to guide empiric anti-anaerobic therapy at their institutions. In conclusion, anaerobe antibiotic susceptibility patterns must be monitored to ensure appropriate antibiotic empiric therapy and stewardship.
Cell-specific MHC class I deletion on CD11c+ APCs abrogates CD8 T Cell infiltration into the brain
Maynes, Mark Andrew, Wolf, Delaney, Tritz, Zachariah P. , Bamkole, Michael , Hansen, Michael J. , Johnson, Aaron J. , Maynes, Mark A , Fain, Cori E. , Ayasoufi, Katayoun , Wolf, Delaney M. , Jin, Fang , Johnson, Aaron J.

Mayo Clinic

The Journal of Immunology | August 10, 2023 | Volume: 210 | Issue: Supplement_1 | Pages: 221.34-221.34

10.4049/jimmunol.210.supp.221.34 Get It

Abstract Cerebral malaria (CM) is a severe complication of P. falciparum infection and a leading cause of death, globally. Plasmodium berghei ANKA (PbA) infection of C57BL/6 mice serves as a murine model of CM called experimental cerebral malaria (ECM) due to the neurological and neuropathological features that simulate the infection of human CM. A putative mechanism of disease in human CM requires CD8 T cell to infiltration into the brain and blood-brain barrier disruption. The specific antigen-presenting cell type(s) that prime this CNS infiltrating CD8 T cell response capable of inducing lethal blood-brain barrier disruption has not been defined. To answer this, single class I expressing Kb loxP transgenic mice were generated. Crossing these mice to class I deficient CD11c-cre or LysM-cre mice created the LysM-cre Kb cKO and CD11c-cre Kb cKO mice, respectively. PbA infected Kb loxP and LysM-cre Kb cKO were susceptible to ECM. In contrast, CD11c-cre Kb cKO mice survived acute PbA infection and avoided neurological manifestations. We therefore employed spectral flow cytometry to analyze splenocytes and brain infiltrating immune cells during acute PbA infection in these genotypes. We observed a reduction in activated CD8 T cells in the spleens of PbA infected CD11c-cre Kb cKO mice versus the Kb loxP mice and the LysM-cre Kb cKO. This reduced peripheral CD8 T cell activation in PbA infected CD11c-cre Kb cKO mice also corresponded with reduced brain infiltration of CD8 T cells. We conclude a CD11c+ APC is therefore required for priming and potentially recruitment of CD8 T cells to the brain during lethal ECM pathology. 5R01NS103212-06
P1169: COMPARISON OF REAL-WORLD CLINICAL OUTCOMES IN PATIENTS WITH RELAPSED/REFRACTORY LARGE B-CELL LYMPHOMA TREATED WITH EPCORITAMAB VS CHEMOIMMUNOTHERAPY
Mutebi, Alex, Wang, Tongsheng , Jun, Monika, Yu, Junhua, Brodkin, Samantha, Sacchi, Mariana, Kalsekar, Anupama, Ip, Andrew , Rosenthal, Allison , Mutebi, Alex , Wang, Anthony , Muñoz, Javier

Mayo Clinic

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e324937a

10.1097/01.hs9.0000971572.32493.7a Get It

Assessment of bleeding risk in low-weight patients receiving prophylactic subcutaneous unfractionated heparin
Jatis, Andrew J. , Nei, Scott D. , Zieminski, Joseph J , Mara, Kristin C. , Krauter, Abby K, Mara, Kristin, Mara, Kristin C

Mayo Clinic

Vascular Medicine | August 9, 2023 | Volume: 28 | Issue: 5 | Pages: 443-448

10.1177/1358863x231189758 | PMID 37555546 Get It

Background: Underweight patients may be at an increased risk of bleeding while receiving venous thromboembolism (VTE) prophylaxis. Additional evidence is needed to identify patient-specific factors associated with bleeding. The objective of the study was to describe the incidence and identify risk factors associated with bleeding in low-weight (⩽ 60 kg) adult patients receiving subcutaneous unfractionated heparin (SQH) for VTE prophylaxis. Methods: This was a single-center, retrospective, nested case–control study of low-weight patients receiving SQH for VTE prophylaxis for ⩾ 48 hours. Cases, patients with clinically relevant bleeding while receiving SQH, and controls, patients without a bleeding event, were matched in a 1:3 ratio for age, sex, primary service (surgical or medical), and time at risk of bleeding on SQH to determine factors associated with bleeding. Results: A total of 3761 patients met the inclusion criteria, of which 38 cases of clinically relevant bleeding were identified. The bleeding incidence was 1% at hospital day 6 and 2.8% at hospital day 14. Most patients in this study (69%) received SQH 5000 units three times daily. ICU admission at SQH start was associated with bleeding, OR 2.97 (95% CI 1.21–7.29). Conclusion: Bleeding in low-weight patients on prophylactic SQH was uncommon. Patients admitted to the ICU at time of SQH start may be at a higher risk of bleeding. Further studies are needed to detect additional risk factors associated with bleeding and investigate the effects of reduced dosing in this population.
P1087: PIRTOBRUTINIB IN COVALENT BTK-INHIBITOR PRE-TREATED MANTLE CELL LYMPHOMA: UPDATED RESULTS AND SUBGROUP ANALYSIS FROM THE PHASE 1/2 BRUIN STUDY WITH >3 YEARS FOLLOW-UP FROM START OF ENROLLMENT
Eyre, Toby A. , Ujjani, Chaitra S. , Alencar, Alvaro J. , Lewis, David , Maddocks, Kami J. , Munir, Talha, Balbas, Minna, Tsai, Donald E. , Wang, Chunxiao , Wang, Michael , Shah, Nirav N. , Jurczak, Wojciech , Zinzani, Pier Luigi , Cheah, Chan Y. , Izutsu, Koji , Ma, Shuo , Flinn, Ian W. , Patel, Krish , Wang, Yucai , Zelenetz, Andrew D.

Mayo Clinic

HemaSphere | August 9, 2023 | Volume: 7 | Issue: S3 | Pages: e45636b5

10.1097/01.hs9.0000971244.45636.b5 Get It

An open natural language processing (NLP) framework for EHR-based clinical research: a case demonstration using the National COVID Cohort Collaborative (N3C)
Liu, Sijia , Wen, Andrew , Wang, Liwei , Fu, Sunyang , Miller, Robert , Williams, Andrew E. , Harris, Daniel R. , Liu, Mei , Abu-el-rub, Noor , Schutte, Dalton, Zhang, Rui , Osborne, John D. , He, Yongqun , Topaloĝlu, Ümit , Hong, Stephanie , Schaffter, Thomas , Fuentes, Rafael , Xu, Hua , He, Huan , Fu, Sunyang , Williams, Andrew , Harris, Daniel , Kavuluru, Ramakanth , Liu, Mei , Zhang, Rui , Rouhizadeh, Masoud , Osborne, John D , He, Yongqun , Topaloglu, Umit , Saltz, Joel H , Schaffter, Thomas , Pfaff, Emily , Chute, Christopher G , Haendel, Melissa , Szolovits, Peter , Xu, Hua , Liu, Hongfang , Liu, Sijia , Wen, Andrew , Abu-El-Rub, Noor , He, Huan , Saltz, Joel , Chute, Christopher G. , Duong, Timothy Q. , Haendel, Melissa , Liu, Hongfang

Mayo Clinic

Journal of the American Medical Informatics Association | August 8, 2023 | Volume: 30 | Issue: 12 | Pages: 2036-2040

10.1093/jamia/ocad134 | PMID 37555837 Get It

Abstract Despite recent methodology advancements in clinical natural language processing (NLP), the adoption of clinical NLP models within the translational research community remains hindered by process heterogeneity and human factor variations. Concurrently, these factors also dramatically increase the difficulty in developing NLP models in multi-site settings, which is necessary for algorithm robustness and generalizability. Here, we reported on our experience developing an NLP solution for Coronavirus Disease 2019 (COVID-19) signs and symptom extraction in an open NLP framework from a subset of sites participating in the National COVID Cohort (N3C). We then empirically highlight the benefits of multi-site data for both symbolic and statistical methods, as well as highlight the need for federated annotation and evaluation to resolve several pitfalls encountered in the course of these efforts.
NCCN Guidelines® Insights: Survivorship, Version 1.2023
Sanft, Tara , Ansbaugh, Shannon, Ballinger, T.J., Demark‐Wahnefried, Wendy , Dickinson, Kristin , Fairman, Nathan, Felciano, Josephine, Flores, Tessa , Gabel, Nicolette , Goldman, Mindy, Henry, N. Lynn , Hill‐Kayser, Christine E. , Koura, Divya, Lee, Kimberly , McDonough, Allison L. , Melisko, Michelle , Mooney, Kathi , Moryl, Natalie , Neuman, Heather B. , Patel, Chirayu G. , Peterson, Lindsay L. , Porpiglia, Andrea S., Rodriguez, Maria Alma , Schapira, Lidia , Smith, Sophia K. , Zee, Phyllis C. , McMillian, Nicole R., Freedman-Cass, Deborah A., Tevaarwerk, Amyé , Henry, N Lynn , Demark-Wahnefried, Wendy , Day, Andrew T. , Armenian, Saro H. , Baker, Kevin Scott , Friedman, Debra L. , Hudson, Melissa M. , Moore, Halle C. F. , O’Connor, Tracey L. , Overholser, Linda , Paskett, Electra D. , Pirl, William F. , Schwartz, Anna L. , Yang, Eric H.

Mayo Clinic

Journal of the National Comprehensive Cancer Network | August 7, 2023 | Volume: 21 | Issue: 8 | Pages: 792-803

10.6004/jnccn.2023.0041 | PMID 37549906 Get It

The NCCN Guidelines for Survivorship are intended to help healthcare professionals address the complex and varied needs of cancer survivors. The NCCN Guidelines provide screening, evaluation, and treatment recommendations for psychosocial and physical problems resulting from adult-onset cancer and its treatment; recommendations to help promote healthy behaviors and immunizations in survivors; and a framework for care coordination. These NCCN Guidelines Insights summarize recent guideline updates and panel discussions pertaining to sleep disorders, fatigue, and cognitive function in cancer survivors.